Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart in IgA Nephropathy
September 06, 2022 16:01 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's...
Eledon Pharmaceuticals to Participate in Two Upcoming Investor Conferences
August 29, 2022 08:00 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that senior management will participate in two upcoming investor...
Eledon Pharmaceuticals Reports Second Quarter 2022 Operating and Financial Results
August 11, 2022 16:01 ET
|
Eledon Pharmaceuticals, Inc.
Received FDA clearance of IND application for Phase 2 trial evaluating tegoprubart for the prevention of rejection in kidney transplant recipients First patient dosed in Phase 1b trial evaluating...
Eledon Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
August 04, 2022 16:05 ET
|
Eledon Pharmaceuticals, Inc.
Management to host conference call and webcast at 4:30 pm ET IRVINE, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical...
GSK Joins American Kidney Fund’s 2022 Corporate Membership Program at ‘Champion’ Level
August 04, 2022 09:00 ET
|
American Kidney Fund
ROCKVILLE, Md., Aug. 04, 2022 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that GSK has joined the 2022 class in its Corporate Membership Program as a Champion-level member,...
American Kidney Fund Announces Renewed Support for Educational Know Your Kidneys™ Campaign
August 01, 2022 09:00 ET
|
American Kidney Fund
ROCKVILLE, Md., Aug. 01, 2022 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Otsuka America Pharmaceutical, Inc. (Otsuka) and Boehringer Ingelheim and Eli Lilly and Company...
Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart for the Prevention of Rejection in Kidney Transplant Recipients
August 01, 2022 05:00 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of...
Esperanza Offers Hope to People on Waiting List
July 29, 2022 11:01 ET
|
Texas Organ Sharing Alliance
San Antonio, Texas, July 29, 2022 (GLOBE NEWSWIRE) -- SAN ANTONIO, TX (July 29, 2022) – Today, Texas Organ Sharing Alliance (TOSA), the organ donation organization serving Central and South Texas,...
American Kidney Fund Hosts National Virtual Camp for Children and Teens with Kidney Disease
July 19, 2022 09:30 ET
|
American Kidney Fund
ROCKVILLE, Md., July 19, 2022 (GLOBE NEWSWIRE) -- Starting this month, 250 children and teens from across the United States will be participating in the American Kidney Fund’s (AKF) first national...
Eledon Pharmaceuticals Announces the First Patient Dosed in Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation
July 18, 2022 08:00 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of...